ROLE OF QUALITY OF LIFE IN HEALTH TECHNOLOGY ASSESSMENT AGENCY FINAL RECOMMENDATIONS: INSIGHTS AND LESSONS FROM REVIEW OF NICE TECHNOLOGY ASSESSMENT REPORTS (2019-2022)

被引：0

作者：

Aggarwal, S. ^{[1
]}

Bela, A. ^{[2
]}

Topaloglu, H. ^{[2
]}

Kumar, S. ^{[3
]}

Topaloglu, O. ^{[1
]}

机构：

[1] NOVEL Hlth Strategies, Bethesda, MD USA

[2] NOVEL Hlth Strategies, Chevy Chase, MD USA

[3] NOVEL Hlth Strategies, Columbia, MD USA

来源：

VALUE IN HEALTH | 2022年 / 25卷 / 12期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

HTA83

引用

页码：S312 / S312

页数：1

共 37 条

[1] ROLE OF REAL-WORLD EVIDENCE FOR TREATMENTS GRANTED ACCESS UNDER CANCER DRUGS FUND: LESSONS AND INSIGHTS FROM REVIEW OF NICE TECHNOLOGY ASSESSMENT REPORTS (2019-2022)
Aggarwal, S.
Topaloglu, H.
Kumar, S.
Bela, A.
Topaloglu, O.
VALUE IN HEALTH, 2022, 25 (12) : S450 - S451
[2] ASSESSMENT OF KEY DRIVERS OF ECONOMIC EVALUATIONS FOR DIGITAL HEALTH AND MEDICAL TECHNOLOGIES: INSIGHTS AND LESSONS FROM REVIEW OF NICE MEDICAL TECHNOLOGY ASSESSMENT REPORTS (2010-2022)
Aggarwal, S.
Topaloglu, J.
Kumar, S.
Bela, A.
Topaloglu, O.
VALUE IN HEALTH, 2022, 25 (12) : S339 - S339
[3] USING REAL-WORLD EVIDENCE FOR HEALTH TECHNOLOGY ASSESSMENT SUBMISSIONS: LESSONS AND INSIGHTS FROM REVIEW OF NICE'S TECHNOLOGY ASSESSMENT REPORTS (2016-2017)
Aggarwal, S.
Topaloglu, O.
Kumar, S.
VALUE IN HEALTH, 2018, 21 : S7 - S7
[4] Predictive validation of modeled health technology assessment claims: lessons from NICE
Belsey, Jonathan
JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (12) : 1007 - 1012
[5] VALUE OF REAL-WORLD EVIDENCE FOR TREATMENTS FOR ULTRA ORPHAN OR RARE DISEASES: LESSONS AND INSIGHTS FROM REVIEW OF NICE HIGHLY SPECIALIZED TECHNOLOGY ASSESSMENT REPORTS (2016-2022)
Aggarwal, S.
Topaloglu, J.
Kumar, S.
Bela, A.
Topaloglu, O.
VALUE IN HEALTH, 2022, 25 (12) : S303 - S303
[6] Reports from the Spanish Agency for Health Technology Assessment (AETS) - Ultrasonography in primary health care
不详
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1999, 15 (04) : 773 - 777
[7] TRENDS IN HTA SUBMISSIONS FOR RARE DISEASES: INSIGHTS FROM REVIEW OF NICE'S HIGHLY SPECIALIZED TECHNOLOGY (HST) ASSESSMENT REPORTS
Aggarwal, S.
Topaloglu, O.
Kumar, S.
VALUE IN HEALTH, 2018, 21 : S264 - S265
[8] HOW IS CARER QUALITY OF LIFE INCLUDED IN HEALTH TECHNOLOGY ASSESSMENT GLOBALLY? A REVIEW OF GUIDANCE, WITH CASE STUDIES AND RECOMMENDATIONS
Pennington, B.
Eaton, J.
Hatswell, A. J.
Taylor, H.
VALUE IN HEALTH, 2022, 25 (12) : S318 - S319
[9] ECONOMIC MODELING INSIGHTS FOR ULTRA ORPHAN DRUGS BASED ON REVIEW OF NICE HIGHLY SPECIALIZED TECHNOLOGY (HST) ASSESSMENT REPORTS
Aggarwal, S.
Kumar, S.
Bela, A.
Topaloglu, O.
VALUE IN HEALTH, 2023, 26 (06) : S266 - S266
[10] A COMPARISON OF HTA RECOMMENDATIONS FOR CANCER TREATMENT TECHNOLOGIES PUBLISHED BY AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT (AHTAPOL) AND NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE)
Kiljan, A.
Kolasa, K.
Hermanowski, T.
VALUE IN HEALTH, 2010, 13 (07) : A280 - A281

← 1 2 3 4 →